03.05.2013
- A once prominent biotechnology investor was handed four years in prison on Thursday after pleading guilty to stock manipulation, the second time he has run afoul of U.S. securities...
French pharma Sanofi is once again boosting its immunotherapy capabilities, this time with the acquisition of UK biotech Kymab. The company will make an upfront payment...
03.04.2013
- AstraZeneca boosted its early-stage pipeline of experimental heart drugs on Wednesday by buying privately held U.S. biotechnology company AlphaCore Pharma, which is developing a...
British drugmaker Indivior has agreed to buy Opiant, a US biotech specializing in treatments for addiction and drug overdose. Indivior will pay about $145 million upfront...
A new venture capital vehicle launched by a group of biotech entrepreneurs is designed to act as a seed investor as well as a drug discovery co-pilot for biotech startups...
15.06.2013
- The unapproved genetically modified wheat that was discovered sprouting in Oregon appears to have been "a single isolated incident," U.S. agricultural officials said on Friday in...
20.06.2012
- Sartorius Stedim Biotech (SSB), an international pharma and biotech supplier, and Bosch Packaging Technology (Bosch), a provider of process technology and packaging solutions for...
11.04.2013
- Biotech firms eager to push drug candidates through clinical trials prompted an overall increase in R&D expenditure of 20% in just a year, research and consulting firm GlobalData...
For an undisclosed sum, Germany’s Evonik has acquired German industrial biotech JeNaCell, thereby expanding its biomaterials portfolio to biotechnologically derived...
Belgian chemical company Solvay is investing an undisclosed sum in Invizius, a UK biotech start-up that is developing a proprietary anti-inflammatory solution for...